Skip to main content

What's Concerning Jim Cramer About the South African Variant of COVID-19

Publish date:
Video Rating:
Video Duration:

AstraZeneca's  (AZN)  vaccine candidate--which has been approved in countries such as the United Kingdom and South Africa, but has not been approved in the U.S.-- has been shown to be not as effective against the South African variant according to a study.

In response, South Africa has halted the rollout of AstraZeneca's COVID-19 vaccine.

But what does this mean for the overall vaccine rollout and how could it impact investors?

Recap TheStreet Live: Everything Jim Cramer Is Watching Monday

Latest Videos From TheStreet and Jim Cramer:


Related Videos